Document Detail


Vasoconstriction in active skeletal muscles: a potential role for P2X purinergic receptors?
MedLine Citation:
PMID:  12766177     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There is evidence that ATP acts as a neurotransmitter in vascular smooth muscle and is coreleased with norepinephrine from sympathetic nerves. We hypothesized that P2X-receptor stimulation with the selective P2X-receptor agonist alpha,beta-methylene ATP would produce vasoconstriction in resting and exercising skeletal muscle. Six mongrel dogs were instrumented chronically with flow probes on the external iliac arteries of both hindlimbs and a catheter in one femoral artery. The selective P2X agonist alpha,beta-methylene ATP was infused as a bolus into the femoral artery catheter at rest and during mild, moderate, and heavy exercise. Intra-arterial infusions of alpha,beta-methylene ATP elicited reductions in vascular conductance of 54 +/- 5, 49 +/- 8, 39 +/- 8, and 30 +/- 6% at rest, 3 miles/h, 6 miles/h, and 6 miles/h at a 10% grade, respectively. The agonist infusions did not affect blood flow in the contralateral iliac artery. To examine whether nitric oxide is responsible for the attenuated vasoconstrictor response to P2X stimulation, the infusions were repeated in the presence of NG-nitro-l-arginine methyl ester. After nitric oxide synthase blockade, intra-arterial infusions of alpha,beta-methylene ATP elicited reductions in vascular conductance of 56 +/- 7, 61 +/- 8, 52 +/- 9, and 40 +/- 7% at rest, 3 miles/h, 6 miles/h, and 6 miles/h at a 10% grade, respectively. P2X-receptor responsiveness was attenuated during exercise compared with rest. Blockade of nitric oxide production did not affect the attenuation of P2X-receptor responsiveness during exercise. These data support the hypothesis that P2X purinergic receptors can produce vasoconstriction in exercising skeletal muscle.
Authors:
John B Buckwalter; Jason J Hamann; Philip S Clifford
Related Documents :
7476057 - Endothelium-mediated control of coronary vascular tone after chronic exercise training.
15298537 - Voluntary physical exercise-induced vascular effects in spontaneously hypertensive rats.
20007857 - Muscle blood flow responses to dynamic exercise in young obese humans.
17111017 - Beneficial effects of isometric strength training on endothelial dysfunction in rats.
923557 - Effect of training on some metabolic changes associated with submaximal endurance exerc...
16953917 - Pelvic floor exercises with biofeedback for stress urinary incontinence.
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.     Date:  2003-05-23
Journal Detail:
Title:  Journal of applied physiology (Bethesda, Md. : 1985)     Volume:  95     ISSN:  8750-7587     ISO Abbreviation:  J. Appl. Physiol.     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-08-11     Completed Date:  2004-04-08     Revised Date:  2013-09-26    
Medline Journal Info:
Nlm Unique ID:  8502536     Medline TA:  J Appl Physiol (1985)     Country:  United States    
Other Details:
Languages:  eng     Pagination:  953-9     Citation Subset:  IM    
Affiliation:
Department of Anesthesiology and Physiology, Medical College of Wisconsin, Milwaukee, WI 53295, USA. jbuckwal@mcw.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / analogs & derivatives*,  pharmacology
Animals
Blood Pressure / drug effects,  physiology
Dogs
Enzyme Inhibitors / pharmacology
Hindlimb / blood supply,  physiology
Muscle, Skeletal / blood supply*,  drug effects
NG-Nitroarginine Methyl Ester / pharmacology
Nitric Oxide / metabolism
Nitric Oxide Synthase / antagonists & inhibitors
Norepinephrine / pharmacology
Physical Exertion / physiology
Purinergic P2 Receptor Agonists
Receptors, Purinergic P2 / physiology*
Regional Blood Flow / drug effects,  physiology
Vasoconstriction / drug effects,  physiology*
Vasoconstrictor Agents / pharmacology
Chemical
Reg. No./Substance:
0/Enzyme Inhibitors; 0/Purinergic P2 Receptor Agonists; 0/Receptors, Purinergic P2; 0/Vasoconstrictor Agents; 10102-43-9/Nitric Oxide; 50903-99-6/NG-Nitroarginine Methyl Ester; 51-41-2/Norepinephrine; 56-65-5/Adenosine Triphosphate; 7292-42-4/alpha,beta-methyleneadenosine 5'-triphosphate; EC 1.14.13.39/Nitric Oxide Synthase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cloning and characterization of hCTF18, hCTF8, and hDCC1. Human homologs of a Saccharomyces cerevisi...
Next Document:  Cluster analysis of muscle functional MRI data.